BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 26466143)

  • 1. Monitoring pharmacologically induced immunosuppression by immune repertoire sequencing to detect acute allograft rejection in heart transplant patients: a proof-of-concept diagnostic accuracy study.
    Vollmers C; De Vlaminck I; Valantine HA; Penland L; Luikart H; Strehl C; Cohen G; Khush KK; Quake SR
    PLoS Med; 2015 Oct; 12(10):e1001890. PubMed ID: 26466143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benefit of immune monitoring in heart transplant patients using ATP production in activated lymphocytes.
    Kobashigawa JA; Kiyosaki KK; Patel JK; Kittleson MM; Kubak BM; Davis SN; Kawano MA; Ardehali AA
    J Heart Lung Transplant; 2010 May; 29(5):504-8. PubMed ID: 20133166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Next generation sequencing based assessment of the alloreactive T cell receptor repertoire in kidney transplant patients during rejection: a prospective cohort study.
    Aschauer C; Jelencsics K; Hu K; Heinzel A; Vetter J; Fraunhofer T; Schaller S; Winkler S; Pimenov L; Gualdoni GA; Eder M; Kainz A; Regele H; Reindl-Schwaighofer R; Oberbauer R
    BMC Nephrol; 2019 Sep; 20(1):346. PubMed ID: 31477052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multicentre, patient- and assessor-blinded, non-inferiority, randomised and controlled phase II trial to compare standard and torque teno virus-guided immunosuppression in kidney transplant recipients in the first year after transplantation: TTVguideIT.
    Haupenthal F; Rahn J; Maggi F; Gelas F; Bourgeois P; Hugo C; Jilma B; Böhmig GA; Herkner H; Wolzt M; Doberer K; Vossen M; Focosi D; Neuwirt H; Banas M; Banas B; Budde K; Viklicky O; Malvezzi P; Rostaing L; Rotmans JI; Bakker SJL; Eller K; Cejka D; Pérez AM; Rodriguez-Arias D; König F; Bond G;
    Trials; 2023 Mar; 24(1):213. PubMed ID: 36949445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular rejection post heart transplantation is associated with positive flow cytometric cross-matching.
    McCarthy JF; Cook DJ; Massad MG; Sano Y; O'Malley KJ; Ratliff NR; Stewart RW; Smedira NG; Starling RC; Young JB; McCarthy PM
    Eur J Cardiothorac Surg; 1998 Aug; 14(2):197-200. PubMed ID: 9755007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Posttransplant peripheral blood donor-specific interferon-γ enzyme-linked immune spot assay differentiates risk of subclinical rejection and de novo donor-specific alloantibodies in kidney transplant recipients.
    Crespo E; Cravedi P; Martorell J; Luque S; Melilli E; Cruzado JM; Jarque M; Meneghini M; Manonelles A; Donadei C; Lloberas N; Gomà M; Grinyó JM; Heeger P; Bestard O
    Kidney Int; 2017 Jul; 92(1):201-213. PubMed ID: 28274484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucocorticosteroid-free versus glucocorticosteroid-containing immunosuppression for liver transplanted patients.
    Fairfield C; Penninga L; Powell J; Harrison EM; Wigmore SJ
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD007606. PubMed ID: 29630730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remote noninvasive allograft rejection monitoring for heart transplant recipients: study protocol for the novel evaluation with home electrocardiogram and remote transmission (NEW HEART) study.
    Doering LV; Hickey K; Pickham D; Chen B; Drew BJ
    BMC Cardiovasc Disord; 2012 Mar; 12():14. PubMed ID: 22386040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunosuppression management in renal transplant recipients with normal-immunological risk: 10-year results from the Swiss Transplant Cohort Study.
    Krisl A; Stampf S; Hauri D; Binet I; Mueller T; Sidler D; Hadaya K; Golshayan D; Pascual M; Koller M; Dickenmann M; The Swiss Transplant Cohort Study Stcs
    Swiss Med Wkly; 2020 Nov; 150():w20354. PubMed ID: 33277913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival.
    Pretagostini R; Cinti P; Lai Q; Poli L; Berloco PB
    Transpl Immunol; 2008 Nov; 20(1-2):3-5. PubMed ID: 18773959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycophenolic acid versus azathioprine as primary immunosuppression for kidney transplant recipients.
    Wagner M; Earley AK; Webster AC; Schmid CH; Balk EM; Uhlig K
    Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD007746. PubMed ID: 26633102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune cell function assay does not identify biopsy-proven pediatric renal allograft rejection or infection.
    Ryan CM; Chaudhuri A; Concepcion W; Grimm PC
    Pediatr Transplant; 2014 Aug; 18(5):446-52. PubMed ID: 24930482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune function assay (ImmuKnow) as a predictor of allograft rejection and infection in kidney transplantation.
    He J; Li Y; Zhang H; Wei X; Zheng H; Xu C; Bao X; Yuan X; Hou J
    Clin Transplant; 2013; 27(4):E351-8. PubMed ID: 23682828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterizing pre-transplant and post-transplant kidney rejection risk by B cell immune repertoire sequencing.
    Pineda S; Sigdel TK; Liberto JM; Vincenti F; Sirota M; Sarwal MM
    Nat Commun; 2019 Apr; 10(1):1906. PubMed ID: 31015506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Daily noninvasive rejection monitoring improves long-term survival in pediatric heart transplantation.
    Hetzer R; Potapov EV; Müller J; Loebe M; Hummel M; Weng Y; Warnecke H; Lange PE
    Ann Thorac Surg; 1998 Oct; 66(4):1343-9. PubMed ID: 9800831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological monitoring of renal transplant recipients to predict acute allograft rejection following the discontinuation of tacrolimus.
    Kreijveld E; Koenen HJ; van Cranenbroek B; van Rijssen E; Joosten I; Hilbrands LB
    PLoS One; 2008 Jul; 3(7):e2711. PubMed ID: 18628993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective Tracking of Donor-Reactive T-Cell Clones in the Circulation and Rejecting Human Kidney Allografts.
    Aschauer C; Jelencsics K; Hu K; Heinzel A; Gregorich MG; Vetter J; Schaller S; Winkler SM; Weinberger J; Pimenov L; Gualdoni GA; Eder M; Kainz A; Troescher AR; Regele H; Reindl-Schwaighofer R; Wekerle T; Huppa JB; Sykes M; Oberbauer R
    Front Immunol; 2021; 12():750005. PubMed ID: 34721420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunosuppressive T-cell antibody induction for heart transplant recipients.
    Penninga L; Møller CH; Gustafsson F; Gluud C; Steinbrüchel DA
    Cochrane Database Syst Rev; 2013 Dec; (12):CD008842. PubMed ID: 24297433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microarray-based gene expression profiles of allograft rejection and immunosuppression in the rat heart transplantation model.
    Erickson LM; Pan F; Ebbs A; Kobayashi M; Jiang H
    Transplantation; 2003 Aug; 76(3):582-8. PubMed ID: 12923448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tacrolimus and cyclosporine differ in their capacity to overcome ongoing allograft rejection as a result of their differential abilities to inhibit interleukin-10 production.
    Jiang H; Wynn C; Pan F; Ebbs A; Erickson LM; Kobayashi M
    Transplantation; 2002 Jun; 73(11):1808-17. PubMed ID: 12085006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.